Toronto Dominion Bank Purchases 24,293 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Toronto Dominion Bank boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 153,690 shares of the company’s stock after purchasing an additional 24,293 shares during the quarter. Toronto Dominion Bank’s holdings in GE HealthCare Technologies were worth $14,424,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP bought a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $26,000. Finally, Elkhorn Partners Limited Partnership bought a new position in shares of GE HealthCare Technologies in the second quarter valued at approximately $31,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.6 %

Shares of NASDAQ GEHC opened at $81.10 on Friday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock has a market capitalization of $37.05 billion, a PE ratio of 22.28, a P/E/G ratio of 2.96 and a beta of 1.07. GE HealthCare Technologies Inc. has a one year low of $71.31 and a one year high of $94.55. The business’s fifty day moving average price is $85.84 and its 200-day moving average price is $83.71.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.99 earnings per share. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is currently 3.30%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. Evercore ISI increased their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price target for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. Finally, Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $95.46.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.